Quarterly Result14 Aug 2026, 04:26 pm
Everest Organics declares Q1 FY27 Un-audited Standalone Results
AI Summary
Everest Organics Ltd announced its Un-audited Standalone Financial Results for the quarter ended June 30, 2026. The Board of Directors approved these results after a meeting that included a reconvened session following an Audit Committee meeting. The company operates in a single business segment: Active Pharmaceutical Ingredients (API) and their Intermediates. The results were reviewed by Statutory Auditors P.S.N. Ravishanker & Associates.
Key Highlights
- Board approved Un-audited Standalone Financial Results for Q1 FY27.
- Results were reviewed by Statutory Auditors.
- Company operates in API and Intermediates segment.
- 2,63,157 Equity Share Warrants outstanding as of June 30, 2026.
- 1,80,686 equity shares held under unclaimed suspense account.
Price Impact
More from EVERESTO